Cargando…
P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA.
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428961/ http://dx.doi.org/10.1097/01.HS9.0000969644.37507.cd |
| _version_ | 1785090596597137408 |
|---|---|
| author | R, Chethan Singh Malik, Prabath Kumar Sahoo, Ranjit Pramannik, Raja Garg, Vikas Kirar, Sudhir Bhatia, Kanupriya Kantak, Anura Sharma, Atul Kumar, Lalit |
| author_facet | R, Chethan Singh Malik, Prabath Kumar Sahoo, Ranjit Pramannik, Raja Garg, Vikas Kirar, Sudhir Bhatia, Kanupriya Kantak, Anura Sharma, Atul Kumar, Lalit |
| author_sort | R, Chethan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428961 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289612023-08-17 P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA. R, Chethan Singh Malik, Prabath Kumar Sahoo, Ranjit Pramannik, Raja Garg, Vikas Kirar, Sudhir Bhatia, Kanupriya Kantak, Anura Sharma, Atul Kumar, Lalit Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428961/ http://dx.doi.org/10.1097/01.HS9.0000969644.37507.cd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters R, Chethan Singh Malik, Prabath Kumar Sahoo, Ranjit Pramannik, Raja Garg, Vikas Kirar, Sudhir Bhatia, Kanupriya Kantak, Anura Sharma, Atul Kumar, Lalit P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA. |
| title | P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA. |
| title_full | P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA. |
| title_fullStr | P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA. |
| title_full_unstemmed | P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA. |
| title_short | P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA. |
| title_sort | p685: late phase bcr-abl decline predicts the duration of tki (imatinib) for successful treatment free remission in chronic myeloid leukemia. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428961/ http://dx.doi.org/10.1097/01.HS9.0000969644.37507.cd |
| work_keys_str_mv | AT rchethan p685latephasebcrabldeclinepredictsthedurationoftkiimatinibforsuccessfultreatmentfreeremissioninchronicmyeloidleukemia AT singhmalikprabath p685latephasebcrabldeclinepredictsthedurationoftkiimatinibforsuccessfultreatmentfreeremissioninchronicmyeloidleukemia AT kumarsahooranjit p685latephasebcrabldeclinepredictsthedurationoftkiimatinibforsuccessfultreatmentfreeremissioninchronicmyeloidleukemia AT pramannikraja p685latephasebcrabldeclinepredictsthedurationoftkiimatinibforsuccessfultreatmentfreeremissioninchronicmyeloidleukemia AT gargvikas p685latephasebcrabldeclinepredictsthedurationoftkiimatinibforsuccessfultreatmentfreeremissioninchronicmyeloidleukemia AT kirarsudhir p685latephasebcrabldeclinepredictsthedurationoftkiimatinibforsuccessfultreatmentfreeremissioninchronicmyeloidleukemia AT bhatiakanupriya p685latephasebcrabldeclinepredictsthedurationoftkiimatinibforsuccessfultreatmentfreeremissioninchronicmyeloidleukemia AT kantakanura p685latephasebcrabldeclinepredictsthedurationoftkiimatinibforsuccessfultreatmentfreeremissioninchronicmyeloidleukemia AT sharmaatul p685latephasebcrabldeclinepredictsthedurationoftkiimatinibforsuccessfultreatmentfreeremissioninchronicmyeloidleukemia AT kumarlalit p685latephasebcrabldeclinepredictsthedurationoftkiimatinibforsuccessfultreatmentfreeremissioninchronicmyeloidleukemia |